Skip to content

Clinical trials

Phase 2 Seizures trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 2 Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20021
20031
20041
20051
20063
20074
20082
20095
20102
20112
20121
20131
20143
20152
20171
20188
20192
20202
20212
20223
20232
20244
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated10
Recruiting8
Unknown status3
Active, not recruiting2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.5
National Institute of Neurological Disorders and Stroke (NINDS)5
Marinus Pharmaceuticals4
GlaxoSmithKline3
Supernus Pharmaceuticals, Inc.3
AbbVie2
Acorda Therapeutics2
Equilibre Biopharmaceuticals B.V.2
NeuroPace2
Rapport Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures62
Epilepsy43
Epilepsies, Partial11
Drug Resistant Epilepsy5
Epilepsy, Reflex3
Heart Arrest3
Anxiety Disorders2
Brain Diseases2
Brain Injuries, Traumatic2
Coma2

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.